此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

胸腔镜下肺部分切除术后经封闭式胸腔引流管连续输注利多卡因控制疼痛

2026年9月20日 更新者:Jinying Zhang、Qilu Hospital of Shandong University

密闭式胸腔引流管持续输注利多卡因对胸腔镜肺部分切除术患者术后镇痛的影响:一项单中心随机对照临床试验

The goal of this clinical trial is to learn about the effects on postoperative analgesia of continuous lidocaine infusion via closed chest drainage tube for patients undergoing thoracoscopic partial lung resection. The main questions it aims to answer are:

  • To explore whether continuous lidocaine pumping via closed chest drainage tube has good analgesic and anti-inflammatory effects for patients undergoing partial thoracoscopic pneumonectomy.
  • Whether the multimodal analgesia combined with continuous lidocaine pump can reduce the postoperative application of opioids, reduce the occurrence of postoperative complications, and promote the recovery of postoperative lung function and accelerate recovery.

For participants who undergoing the thoracoscopic partial lung resection with postoperative indwelling drainage tube, the epidural tube fixed in the drainage tube is connected to the completed infusion pump (marking the chest drain for analgesia). The comparison group only accept the intravenous analgesia after surgery.

研究概览

详细说明

At present, multimodal analgesia has been the most commonly used approaches for the treatment of postoperative pain of thoracic surgery, including steroidal anti-inflammatory drugs, administration of opioid, and local anesthesia.

The investigators found that continuous lidocaine analgesia with local anesthesia through thoracic closed drainage tube could improve postoperative pain caused by drainage tube retention, reduce postoperative pain score, and improve postoperative recovery of respiratory function in patients. In the protocol, lidocaine was continuously pumped with a superficial anesthetic effect on the pleura, while mucosal absorption was almost equivalent to intravenous infusion, so its systemic anti-inflammatory effect is also explored.

In the protocol,participants will be randomized in a 1:1 ratio to the control or experimental groups. The experimental group received a continuous infusion of lidocaineThe experimental group used 2% lidocaine 100ml, and the control group was the conventional treatment group. The control group received only standard intravenous analgesia。In addition to receiving simple intravenous analgesia, the experimental group also received continuous infusion of lidocaine in the pleural cavity.

研究类型

介入性

注册 (实际的)

451

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Shandong
      • Jinan、Shandong、中国
        • Qilu Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 70年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. participants ages 18-70 years.
  2. participants undergoing thoracoscopic partial lung resection with an indwelling drainage tube after surgery.
  3. American Society of Anesthesiologists classification (ASA)I-III.

Exclusion Criteria:

  1. severe heart failure, cardiac arrhythmias,the New York Heart Association(NYHA) classification≥III.
  2. hypersensitivity to lidocaine,History of local anesthetic poisoning.
  3. severe renal or hepatic dysfunction.
  4. body mass index (BMI)>35 kg m-2.
  5. severe pleural adhesions.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Lidocaine (intrapleural continuous infusion) + reduced-dose sufentanil PCIA

Patients receive continuous intrapleural lidocaine infusion via the closed chest drainage tube (pulse 1 mL/30 min + continuous 2 mL/h) combined with reduced-dose sufentanil patient-controlled intravenous analgesia (PCIA, 1.0-1.5 µg/kg for 48 h).

Continuous intrapleural infusion via epidural tube fixed in the closed chest drainage tube, connected to an electronic analgesic pump (pulse 1 mL/30 min + continuous 2 mL/h).

Patient-controlled intravenous analgesia (PCIA): reduced dose 1.0-1.5 µg/kg in the lidocaine arm, standard dose 2.0-2.5 µg/kg in the control arm, both for 48 h.

有源比较器:Standard-dose sufentanil PCIA

Patients receive standard-dose sufentanil PCIA (2.0-2.5 µg/kg for 48 h) alone.

Patient-controlled intravenous analgesia (PCIA): reduced dose 1.0-1.5 µg/kg in the lidocaine arm, standard dose 2.0-2.5 µg/kg in the control arm, both for 48 h.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
postoperative pain score(NRS)
大体时间:Day 1

The primary outcome is the incidence of a numeric rating scale (NRS) pain score > 3 on coughing/movement at 24 hours postoperatively (movement-evoked pain only).

Day 1

次要结果测量

结果测量
措施说明
大体时间
Changes in postoperative pain
大体时间:Day 2

Changes in postoperative pain score (NRS) at 12h and 48h until extubation. The full name of NRS score is Numerical Rating Scale. The minimum value of NRS score is 0 and the maximum value is 10. Patients can score themselves according to the pain level corresponding to the number, A score of 0 represents painless, 1-3 represents mild pain, 4-6 represents moderate pain and should be intervened, 7-10 represents severe pain and requires urgent treatment.

Day 2
the use of flurbiprofen axetil
大体时间:Day 3

the amount of rescue analgesic drugs flurbiprofen axetil used

Day 3
the use of dolantin
大体时间:Day 3

the amount of rescue analgesic drugs dolantin used

Day 3
the use of opioids
大体时间:Day 2

total amount of opioid use within 48h after surgery

Day 2
postoperative adverse events
大体时间:Day 3

the incidence of nausea, vomiting, and vertigo after surgery

Day 3
the amount of postoperative wound drainage
大体时间:Day 3

total amount of fluid drained after surgery

Day 3
C-reactive protein
大体时间:Day 1

The inflammatory marker of participants will be test after surgery

Day 1
interleukin-6
大体时间:Day 1

The inflammatory marker of participants will be test after surgery

Day 1
postoperative delusion
大体时间:Day 3

The incidence of postoperative delusion.

Day 3
drainage extraction
大体时间:up to 24 hours (before extubation)

The time taken for the patient to remove the drain after surgery

up to 24 hours (before extubation)
ICU stay time
大体时间:From date of ICU admission until the date of leaving ICU, assessed up to 5 days.

The length of time the patient remains in the ICU.

From date of ICU admission until the date of leaving ICU, assessed up to 5 days.
postoperative pulmonary complications
大体时间:Day 3

The probability of patients acquiring pulmonary complications after surgery.

Day 3
hospital length of stay
大体时间:From date of hospital admission until the date of discharge,assessed up to 15 days.

The time between hospital admission and discharge

From date of hospital admission until the date of discharge,assessed up to 15 days.
healing rate of drainage wound
大体时间:Day 21

The healing rate of drainage wound at 21 days after surgery.

Day 21
readmission rate
大体时间:Month 1

The readmission rate of patients in one month after surgery.

Month 1

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2023年6月7日

初级完成 (实际的)

2023年12月22日

研究完成 (实际的)

2023年12月30日

研究注册日期

首次提交

2023年5月3日

首先提交符合 QC 标准的

2023年6月12日

首次发布 (实际的)

2023年6月13日

研究记录更新

最后更新发布 (实际的)

2026年9月24日

上次提交的符合 QC 标准的更新

2026年9月20日

最后验证

2023年7月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅